Phase II Study of Trastuzumab (NSC-688097) in Treatment of Locally Advanced or Metastatic Synovial Sarcoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Trastuzumab (Primary)
- Indications Sarcoma
- Focus Therapeutic Use
- 24 Jun 2013 Biomarkers information updated
- 04 Nov 2008 Checked against ClinicalTrials.gov record.
- 06 Aug 2007 Status changed from initiated to completed.